文献速递瓣膜病与结构性心脏病血脂与心血管预防

经导管主动脉瓣植入术后沉默性脑梗死与早期认知结局:系统评价与荟萃分析

Silent brain infarcts and early cognitive outcomes after transcatheter aortic valve implantation: a systematic review and meta-analysis.
PubMed 文献 · Eur Heart J · 2021-01-01

该系统评价与荟萃分析纳入39项研究共2408例TAVI患者,发现术后弥散加权磁共振检出的沉默性脑梗死汇总发生率为0.76(95%CI 0.72-0.81),报告的有局灶神经功能缺损的卒中发生率为3%。糖尿病、慢性肾病、3特斯拉磁共振和预扩张与沉默性脑梗死风险增加相关,早期术后认知功能障碍患病率随随访从10.0±6.3天的16%升至6.1±1.7个月的26%。

要点

  • TAVI术后沉默性脑梗死常见,汇总发生率为0.76(95%CI 0.72-0.81)。
  • 糖尿病、慢性肾病、3特斯拉磁共振和预扩张与沉默性脑梗死风险增加相关。
  • 脑栓塞保护装置似可减小沉默性脑梗死体积,但未降低总体发生率。

核心结论

  • TAVI术后沉默性脑梗死常见,糖尿病、肾病和预扩张增加总体风险。
  • 更多的新发沉默性脑梗死似乎对早期神经认知结局有不良影响。
  • 脑栓塞保护装置未显著降低沉默性脑梗死的发生。

研究设计与样本

  • 系统文献综述纳入39项报告TAVI术后弥散加权磁共振检出沉默性脑梗死发生率的 publications,共2408例患者。
  • 采用荟萃分析和荟萃回归模型评估沉默性脑梗死发生率、基线特征和早期术后认知功能障碍发生率。

主要发现

  • 2171例术后行弥散加权磁共振的患者中,1601例发现至少一个新发沉默性脑梗死,汇总效应量为0.76(95%CI 0.72-0.81)。
  • 报告的有局灶神经功能缺损的卒中发生率为3%。
  • 早期术后认知功能障碍患病率从10.0±6.3天的16%升至6.1±1.7个月的26%。
  • 荟萃回归提示新发沉默性脑梗死的平均数量与术后认知功能障碍发生率之间存在关联。
  • 脑栓塞保护装置的使用似可减小沉默性脑梗死体积,但未降低其总体发生率。

关键数值与推荐

  • 沉默性脑梗死汇总效应量为0.76(95%CI 0.72-0.81),基于2171例术后行弥散加权磁共振的患者。
  • 报告的有局灶神经功能缺损的卒中发生率为3%。
  • 早期术后认知功能障碍患病率在10.0±6.3天为16%,在6.1±1.7个月为26%。
  • 糖尿病、慢性肾病、3特斯拉磁共振和预扩张与沉默性脑梗死风险增加相关。

临床怎么用

  • TAVI术前应关注糖尿病和慢性肾病等沉默性脑梗死高危因素。
  • 预扩张与沉默性脑梗死风险增加相关,临床决策时需权衡。
  • 脑栓塞保护装置可能减小沉默性脑梗死体积,但未降低总体发生率。
  • 术后应关注早期认知功能障碍,尤其在新发沉默性脑梗死数量较多的患者中。

局限性

  • 长期随访研究仍属必要,尤其随着TAVI向低危患者人群扩展。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Silent brain infarcts (SBIs) are frequently identified after transcatheter aortic valve implantation (TAVI), when patients are screened with diffusion-weighted magnetic resonance imaging (DW-MRI). Outside the cardiac literature, SBIs have been correlated with progressive cognitive dysfunction; however, their prognostic utility after TAVI remains uncertain. This study's main goals were to explore (i) the incidence of and potential risk factors for SBI after TAVI; and (ii) the effect of SBI on early post-procedural cognitive dysfunction (PCD). METHODS AND RESULTS: A systematic literature review was performed to identify all publications reporting SBI incidence, as detected by DW-MRI after TAVI. Silent brain infarct incidence, baseline characteristics, and the incidence of early PCD were evaluated via meta-analysis and meta-regression models. We identified 39 relevant studies encapsulating 2408 patients. Out of 2171 patients who underwent post-procedural DW-MRI, 1601 were found to have at least one new SBI (pooled effect size 0.76, 95% CI: 0.72-0.81). The incidence of reported stroke with focal neurological deficits was 3%. Meta-regression noted that diabetes, chronic renal disease, 3-Tesla MRI, and pre-dilation were associated with increased SBI risk. The prevalence of early PCD increased during follow-up, from 16% at 10.0 ± 6.3 days to 26% at 6.1 ± 1.7 months and meta-regression suggested an association between the mean number of new SBI and incidence of PCD. The use of cerebral embolic protection devices (CEPDs) appeared to decrease the volume of SBI, but not their overall incidence. CONCLUSIONS: Silent brain infarcts are common after TAVI; and diabetes, kidney disease, and pre-dilation increase overall SBI risk. While higher numbers of new SBIs appear to adversely affect early neurocognitive outcomes, long-term follow-up studies remain necessary as TAVI expands to low-risk patient populations. The use of CEPD did not result in a significant decrease in the occurrence of SBI.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Woldendorp K, Indja B, Bannon PG, et al. Silent brain infarcts and early cognitive outcomes after transcatheter aortic valve implantation: a systematic review and meta-analysis. Eur Heart J. 2021. PMID: 33517376. doi:10.1093/eurheartj/ehab002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。